# InMed Pharmaceuticals Inc.: Form 8-K, filed Jul 22, 2026

- Company: [InMed Pharmaceuticals Inc.](/companies/inm.md) (CIK 1728328)
- Form: 8-K
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 16:28 ET
- Period: 2026-07-22
- Accession: 0001213900-26-080414
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1728328/000121390026080414/ea0298644-8k425_inmed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1728328/000121390026080414/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1728328/000121390026080414/ea0298644-8k425_inmed.htm

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-080414. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.